女性肥胖与辅助生殖对无并发症妊娠和健康分娩的影响:比利时法兰德斯地区428336例出生研究
该登记研究分析比利时法兰德斯地区2009-2015年428336名女性的数据,评估BMI与医学辅助生殖(MAR)对无并发症妊娠和健康婴儿复合结局的影响。结果显示,BMI较高且使用MAR的女性妊娠和分娩并发症风险最高,且随着BMI类别升高,无并发症妊娠和健康婴儿的预测概率在MAR与非MAR使用者中均降低。
要点
- BMI较高且使用MAR的女性妊娠和分娩并发症风险最高。
- BMI为25 kg/m²时,自然受孕者无并发症妊娠和分娩的预测概率为0.33(0.32至0.35),高于激素刺激者的0.28(0.24至0.32)和IVF/ICSI者的0.26(0.22至0.29)。
- BMI为30 kg/m²时,自然受孕者无并发症妊娠和分娩的预测概率为0.28(0.26至0.30),激素刺激者为0.22(0.16至0.29),IVF/ICSI者为0.20(0.14至0.26)。
核心结论
- BMI较高且使用MAR的女性妊娠和分娩并发症风险最高。
- 作者认为MAR前减重干预似乎合理,但其成本效果需紧急研究。
研究设计与样本
- 基于登记的研究,使用比利时法兰德斯地区围产期流行病学研究中心的2009-2015年数据库,纳入428336名女性。
- 平均年龄30.0岁(SD 4.78),194061名(45.31%)为初产妇,6.3%(n=26971)通过MAR受孕。
- 采用泊松回归,调整母亲年龄、产次、孕期增重、吸烟和既往剖宫产。
主要发现
- 36.80%(n=157623)的女性按所用定义拥有无并发症妊娠和分娩。
- BMI为25 kg/m²时,自然受孕者无并发症妊娠和分娩的预测概率为0.33(0.32至0.35),激素刺激者为0.28(0.24至0.32),IVF/ICSI者为0.26(0.22至0.29)。
- BMI为30 kg/m²时,自然受孕者无并发症妊娠和分娩的预测概率为0.28(0.26至0.30),仅激素刺激者为0.22(0.16至0.29),IVF/ICSI者为0.20(0.14至0.26)。
- 随着BMI类别升高,MAR和非MAR使用者的无并发症妊娠和分娩预测概率均降低。
- BMI为25 kg/m²时,自然受孕者健康婴儿的预测概率为0.92(0.91至0.93),仅激素刺激者为0.89(0.87至0.92),IVF/ICSI者为0.85(0.84至0.87)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 数据库未包含社会经济状况、孕前疾病和父亲BMI的数据,因此分析中无法调整这些因素。
- 作者认为MAR前减重干预似乎合理,但其成本效果需紧急研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the impact of BMI on uncomplicated pregnancies and healthy births in women who did or did not have medically assisted reproduction (MAR, i.e. ART or hormonal stimulation without manipulation of eggs or embryos) in the Flanders region (Belgium)? SUMMARY ANSWER: Women with a higher BMI who use MAR are at the highest risk of pregnancy and birth complications. WHAT WE KNOW ALREADY: Medically assisted reproduction (MAR) is used increasingly worldwide and is associated with increased risk of adverse perinatal outcomes. Obesity is also increasing globally and obese women are more likely to seek MAR since obesity is associated with infertility. When obese women undergo MAR, the risk of adverse outcomes may be enhanced but it is not clear to what extent. STUDY DESIGN, SIZE, DURATION: We conducted a registry-based study using the data from the Study Centre for Perinatal epidemiology database for years 2009-2015, region of Flanders, Belgium. This included 428 336 women. PARTICIPANTS/MATERIALS, SETTING, METHODS: The average age was 30.0 years (SD 4.78), 194 061 (45.31%) were nulliparous, and 6.3% (n = 26 971) conceived with MAR. We examined the association of BMI and MAR with the following composite primary outcomes: 'uncomplicated pregnancy and birth' and 'healthy baby'. We conducted Poisson regression and adjusted for maternal age, parity, gestational weight gain, smoking and previous caesarean section. MAIN RESULTS AND THE ROLE OF CHANCE: In our study, 36.80% (n = 157 623) of women had an uncomplicated pregnancy and birth according to the definition used. The predicted probability of having an uncomplicated pregnancy and birth for women with a BMI of 25 kg/m2 who conceived spontaneously was 0.33 (0.32 to 0.35), while it was 0.28 (0.24 to 0.32) for women who used hormonal stimulation and 0.26 (0.22 to 0.29) for women who used IVF/ICSI. This probability reduced with increasing BMI category for both MAR and non-MAR users. For women with a BMI of 30 kg/m2, the predicted probability of having an uncomplicated pregnancy and birth was 0.28 (0.26 to 0.30) for women who conceived spontaneously, and 0.22 (0.16 to 0.29) and 0.20 (0.14 to 0.26) for women who used hormonal stimulation only or IVF/ICSI, respectively. The predicted probability of having a healthy baby for women with a BMI of 25 kg/m2 who conceived spontaneously was 0.92 (0.91 to 0.93), 0.89 (0.87 to 0.92) for women who used hormonal stimulation only and 0.85 (0.84 to 0.87) for women who used IVF/ICSI. LIMITATIONS, REASONS FOR CAUTION: The database did not include data on socio-economic status, pre-pregnancy morbidities and paternal BMI. Subsequently, we could not adjust for these factors in the analysis. WIDER IMPLICATIONS OF THE FINDINGS: Obese women who use MAR are at the highest risk of pregnancy and birth complications. This increase in interventions also has cost and resource implications which is relevant for funding policies. Weight loss interventions prior to MAR seem plausible but their (cost-) effectiveness needs urgent investigation. STUDY FUNDING/COMPETING INTEREST(S): F.W. received an Erasmus Plus training grant to visit A.B., L.A. and R.D. and conducted this study during this visit. The authors have no competing interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wuytack F, Devlieger R, Ameye L, et al. Impact of female obesity and assisted reproduction on uncomplicated pregnancies and healthy births: a study of 428 336 births in Flanders. Hum Reprod. 2023. PMID: 36256863. doi:10.1093/humrep/deac221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。